To screen or not to screen – that is the Covid question for rheumatologists

Experts have advised against screening rheumatology patients for SARS-CoV-2 because not enough is known about current screening tests and the practice could lead to false reassurance and unnecessary anxiety. Writing in the Annals of...

Experts have advised against screening rheumatology patients for SARS-CoV-2 because not enough is known about current screening tests and...

Osteoporosis

How to build an Osteoporosis Refracture Prevention network – the NSW lesson

It’s taken a quarter of a century, but NSW has led the way in creating a network of Osteoporosis Refracture Prevention services that now cover every Local Health District (LHD) in the state, according to Sydney rheumatologist Professor Lyn March. Speaking...

It’s taken a quarter of a century, but NSW has led the way in creating a network of Osteoporosis Refracture...

Autoinflammatory diseases

Glucocorticoid use a risk factor for more severe outcomes in COVID-19

People with rheumatic disease who develop COVID-19 may be at risk of more severe disease, especially if they are on moderate- to high-dose glucocorticoids, a new study suggests. However, the review of COVID-19 outcomes for patients with immune-mediated inflammatory disease (IMID)...

People with rheumatic disease who develop COVID-19 may be at risk of more severe disease, especially if they are on...

Rheumatoid arthritis

Risk prediction tool developed for RA-associated ILD

A CT-based risk prediction tool developed specifically for patients with RA-associated interstitial lung disease (RA-ILD) has been shown to be more accurate than tools developed for patients with idiopathic pulmonary fibrosis (IPF). The new model is based on four significant risk...

A CT-based risk prediction tool developed specifically for patients with RA-associated interstitial lung disease (RA-ILD) has been shown to be...